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ABSTRACT
HLA class II proteins are important elements of human adaptive immune recognition
and are associated with numerous infectious and immune-mediated diseases. These
highly variable molecules can be classified into DP, DQ and DR groups. It has been
proposed that in contrastwithDP andDR, epitope binding byDQvariants rather results
in immune tolerance. However, the pieces of evidence are limited and controversial.We
found that DQ molecules bind more human epitopes than DR. Pathogen-associated
epitopes bound by DQ molecules are more similar to human proteins than the ones
bound by DR. Accordingly, DQ molecules bind epitopes of significantly different
pathogen species. Moreover, the binding of autoimmunity-associated epitopes by DQ
confers protection from autoimmune diseases. Our results suggest a special role of
HLA-DQ in immune homeostasis and help to better understand the association of
HLA molecules with infectious and autoimmune diseases.
Subjects Computational Biology, Immunology
Keywords HLA-DQ, Epitopes, Autoimmunity, Immune tolerance, Immune recognition, Antigen
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INTRODUCTION
HLA molecules have an essential role in adaptive immune recognition (Trowsdale, 2011).
HLA class II molecules reside on antigen presenting cells and bind protein fragments of
endogenous and exogenous peptides (Trowsdale, 2011). The HLA-peptide complex then
can be recognized by T cell receptors and induce enhanced immune response or tolerance
(Robinson & Delvig, 2002). The equilibrium between immune-mediated elimination and
tolerance is crucial for a healthy immune homeostasis (Murphy et al., 2012).
HLA class II molecules can be classified into DP, DQ and DR groups (Trowsdale, 2011).
All molecules are made up by an alpha and a beta chain (Jones et al., 2006). Both chains
of DP and DQ as well as the beta chain of DR are highly variable (Murphy et al., 2012).
HLA class II molecules are associated with numerous diseases like autoimmunity, allergy
and different kinds of infections (Karnes et al., 2017). To note, most diseases are associated
with DQ and DR, while DP has a lower impact (Karnes et al., 2017). Consequently, our
study focuses on the former two molecules.
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Previous studies reported important specialities in the localization, expression and
function of DQ molecules. HLA-DQ is more abundant in the thymus than in the
periphery (Douek & Altmann, 2000). Additionally, while DR is expressed in both the
thymic cortex and medulla, DQ dominantly prevail in the cortex (Ishikura, Ishikawa &
Aizawa, 1987) suggesting a special—rather suppressive—role of the molecule in immune
homeostasis (Altmann, Sansom &Marsh, 1991). This expression pattern is the result
of many transcriptional and post-transcriptional regulatory mechanisms (Kobr et al.,
1990; Miwa, Doyle & Strominger, 1987). The suppressive behavior of DQ is suggested
by several findings, some of which are related to the association of HLA-DQ alleles with
autoimmunity. First, risk alleles for type 1 diabetesmellitus show a recessive behavior (Todd,
1990). It suggests that in case of heterozygosity, the other allele—being not associated with
the disease—is able to induce tolerance in the thymus. Second, it has been shown that
intrinsic stability of DQ molecules mediates susceptibility to autoimmune disorders
(Miyadera et al., 2015). Unstable complexes cannot present self-peptides and, thus, central
tolerance is not induced, which results in autoimmunity. Some associations between
HLA-DQ and infectious diseases also suggest its dominant role in tolerance induction:
it has been shown that HLA-DQ mediates non-responsiveness to Schistosoma japonicum,
Mycobacterium leprae and BCG antigen through antigen-specific immune suppression
(Hirayama et al., 1987; Ottenhoff et al., 1990; Salgame, Convit & Bloom, 1991). However,
the predominantly suppressive role of DQ in immune homeostasis remained controversial
as DQ-mediated proliferative responses are also reported for both autoimmune and
infectious diseases (Glanville et al., 2017; Van Lummel et al., 2014).
Based on previous findings, we hypothesized that HLA-DQ has an essential role in the
induction of tolerancemechanisms.We carried out systematic analyses of experimental and
computationally predicted data to test four relevant predictions of the hypothesis: (i) DQ
molecules bind more human epitopes, (ii) DQ-bound epitopes of pathogens are more
similar to human proteins, than DR-bound ones, (iii) DQ and DR molecules recognize
epitopes of different pathogen species and (iv) binding of autoantigens by HLA-DQ
molecules confer protection from autoimmune diseases. Our findings highly supported
the suppressive behavior of HLA-DQ molecules. Additionally, our results could help to
better understand the adaptive immune recognition of pathogens and the development of
autoimmune diseases.
METHODS
Determining epitope sequence similarity to human proteins
To determine epitope similarity to human proteins, in vitro HLA binding and T cell
assay data were downloaded from the Immune Epitope Database (IEDB) (Vita et al.,
2015). Positive assay results indicating the binding of 15 amino acids long epitopes by
HLA-DQ and/or HLA-DR molecules were collected. Results for human epitopes were
discarded. The human reference proteome was downloaded from Uniprot (The UniProt
Consortium, 2017) and epitope sequences found in it were also discarded. Next, highly
similar epitope sequences were excluded using an iterative method. First, a protein distance
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matrix containing k-tuple distance values between all possible epitope pairs was generated
with Clustal Omega (Sievers et al., 2011; Yang & Zhang, 2008). In each iteration, epitope
pair (or pairs) with the smallest distance value were identified. For each member of the
epitope pair (or pairs), the mean distance value to all other peptides was calculated and the
epitope with the smallest value was excluded. The iterations were repeated until only larger
than 0.5 k-tuple distance values remained in the matrix. This value corresponds to ∼50%
difference between the two sequences. This filtering process was carried out for HLA-DQ
and HLA-DR epitope set separately resulting in 1476 and 4077 epitopes, respectively.
Each epitope sequence was decomposed to five amino acid long peptides (5-mers).
For each 5-mer, the number of times it prevails in the human reference proteome was
determined. For both DQ- and DR-associated epitopes, the proportion of 5-mers found for
a given time in the human proteome were calculated. If one 5-mer could be detected more
times in epitope sequences, all occurrences were taken into account. Similarly to a recent
paper (Trost et al., 2012), we defined rare 5-mers in three different ways: 5-mers occurring
0 times, 5-mers occurring two or fewer times and 5-mers occurring five or less times in the
human proteome. The epitope set containing significantly less rare 5-mers was considered
to be more similar to human proteins. The level of significance was calculated with a
randomization test. In each iteration, peptides of the original epitope set were randomly
assigned to DR and DQ and the 5-mer analysis was carried out on these sequences. The
epitope randomization and 5-mer analysis process was repeated for ten thousand times.
P value was defined as the probability of having larger or equal difference between the
proportion of rare or common 5-mers in DQ and DR-associated epitopes by chance than
what we found (i.e., the number of such cases divided by the total number of iterations).
Determining the species specificity of DQ and DR
HLA-II epitope sequences of pathogen species were downloaded from IEDB (Vita et al.,
2015). Obligate intracellular pathogens were excluded from the analysis and highly similar
sequences were discarded as described previously. Species with at least 25 epitopes available
were selected for further analysis. Reference proteome of all species were downloaded
from the Uniprot database (The UniProt Consortium, 2017). Epitopes found in only one
proteome (i.e., species specific epitopes)were kept for further analysis. The previous filtering
processes resulted in 1247 epitope sequences of 11 pathogens (Table S1). Common HLA-
DRB1, DQA1 and DQB1 alleles were collected from the Common and Well Documented
(CWD) Alleles Catalog (Mack et al., 2013). All HLA-DQA1-DQB1 allele combinations
were generated and forbidden allele combinations were excluded (Raymond et al., 2005).
The binding of each epitope by each common DRB1 allele or DQA1-DQB1 allele pair
was predicted with the NetMHCIIpan-3.1 computer algorithm (Andreatta et al., 2015).
We used the 10% rank percentile measure to define binding as suggested by a recent
NetMHCIIpan server update. The fraction of epitopes bound by each allele was calculated
for each pathogen. A matrix was created containing these values and hierarchical clustering
was carried out to find similar alleles based on their recognition of species. For each
pathogen, allele-specific recognition values were scaled and centered. Ward clustering
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algorithm was used with the implementation of Ward’s clustering criterion (Murtagh &
Legendre, 2014). Clustering and visualization were carried out with pheatmap R library
(Kolde, 2012).
To confirm in silico results with in vitro data, we used scoring matrices. Epitopes of each
species were examined separately. Sequences longer than 15 amino acids were decomposed
to 15 amino acid long sequences and score was calculated for each resultant peptide.
Epitope sets created for the 5-mer analysis were used to generate scoring matrices. Before
generating matrices, epitopes of the examined species were excluded from the epitope sets.
The prevalence of each amino acid at each of the 15 positions of the epitope sequences
was determined separately for the DQ and the DR-associated epitopes. This resulted in
two different scoring matrices, which were used to assess the probability of binding the
examined epitope by HLA-DQ and DR molecules. For each epitope of the examined
species, we calculated two scores reflecting its binding by HLA-DQ and HLA-DR. The
scores were determined by summing the values in the scoring matrices, which correspond
to the given amino acids at the 15 positions of the examined epitope. For example, if an
alanine was the first amino acid in the epitope sequence, we took the prevalence value
for alanine at the first position from the scoring matrix. We repeated this process for all
positions and summed the 15 values. Binding scores of the examined species’ epitopes
to HLA-DQ and HLA-DR were compared with Wilcoxon rank sum test. P values were
adjusted using the Benjamini–Hochberg procedure (Benjamini & Hochberg, 1995).
Determining the relationship between auto-epitope binding and
susceptibility to autoimmune diseases
Associations between HLA alleles (or certain amino acids in allele sequences) and
autoimmune diseases were collected from the PheWAS catalog (Karnes et al., 2017).
These data were generated using HLA typing of a large population with detailed disease
information. To our knowledge, PheWAS catalog is the only comprehensive source of
HLA-disease associations. Associations with P value less than 10−5 were considered
to be significant as previously suggested (Karnes et al., 2017). Data about the following
autoimmune diseases were collected: type 1 diabetes, Graves’ disease, systemic lupus
erythematosus, celiac disease,multiple sclerosis, primary biliary cirrhosis, systemic sclerosis,
rheumatoid arthritis, juvenile rheumatoid arthritis, dermatomyositis and polymyalgia
rheumatica. Only associations with exact disease terms were included in the analysis and
terms that are only related to the diseases (for example ‘‘Type 1 diabetes with ketoacidosis’’)
were excluded. Epitope sequences associated with each disease were collected from the
IEDB (Vita et al., 2015). Sequences were discarded, if less than two references supported
their role in disease development. After excluding diseases with lack of epitope sequence
data, the following ones remained for further analysis: type 1 diabetes, Graves’ disease,
celiac disease, multiple sclerosis, primary biliary cirrhosis and rheumatoid arthritis. It is
important to note that the catalog contains associations between diseases and individual
DQA1 or DQB1 alleles, but not allele pairs. However, epitope binding of DQ molecules
is determined by both alpha and beta chains (Murphy et al., 2012). As a solution, we
selected all common allele pairs from the set we already generated (described previously),
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which contain the given disease-associated allele. For each allele pair, we determined
the fraction of disease-associated epitopes bound using the NetMHCIIpan algorithm as
described previously (Andreatta et al., 2015). The median of these values defined the level
of auto-epitope binding by the original disease-associated allele. Auto-epitope binding by
DRB1 alleles were determined by calculating the fraction of disease-associated epitopes
bound by the given disease-associated allele.
To examine associations between amino acids and autoimmune diseases, amino acid
sequences of DQA1 andDQB1 alleles were downloaded from the IPD-IMGT/HLA database
(Robinson et al., 2015). For each disease-associated amino acid, we selected common allele
pairs containing the given amino acid in the given position. For each allele pair, we
determined the bound fraction of auto-epitopes and calculated the median of these
values to describe the level of auto-epitope binding associated with the given amino acid.
The difference between auto-epitope binding by susceptibility, neutral and protective
alleles was detected using Kruskal-Wallis test. Pairwise comparison was carried out with
Wilcoxon rank sum tests. P values were adjusted using the Benjamini–Hochberg procedure
(Benjamini & Hochberg, 1995).
RESULTS
HLA-DQ molecules bind more human epitopes than HLA-DR
The hypothesis that DQ molecules are associated with the induction of tolerance predicts
that they bindmore human epitopes thanDR. To test this prediction, we collected results of
all in vitro binding assays for human epitopes from the Immune Epitope Database (IEDB)
(Vita et al., 2015). We selected 1079 epitope sequences, whose binding was tested to both
DQ and DR alleles. We calculated the number of positive and negative assay results for DQ
and DR and found a higher proportion of positive binding assays for DQ alleles (OR: 1.78,
Fisher exact test P: 2∗10−22). This result suggests a higher chance for the binding of human
epitopes by DQ than by DR. To exclude the possibility that this is caused by a generally
higher epitope binding capacity of DQ molecules, we collected assay results also for all
non-human epitopes and selected 2289 sequences, whose binding was tested to both DQ
and DR alleles. Reassuringly, we got the opposite result: the proportion of positive assays
was higher for DR molecules than for DQ (OR: 1.36, Fisher exact test P = 1.8∗10−42).
Epitopes of pathogens bound by HLA-DQ molecules are more similar
to human proteins, than the ones bound by HLA-DR
We found a higher chance for binding human epitopes by DQ molecules than by DR.
This suggests that epitopes of pathogens, which are bound by HLA-DQ might be more
similar to human proteins than the ones bound by DR. To determine similarity of DQ
and DR-associated epitopes to human proteins, we used an established method (Trost
et al., 2012). Five amino acids long peptide segments (5-mers) are reported to be units
of immunological recognition and protein-protein interactions (Lucchese et al., 2007).
We downloaded positive in vitro MHC binding and T cell assay results for DQ and DR
molecules from the IEDB (Vita et al., 2015). We selected 15 amino acid long sequences,
excluded results for human epitopes and discarded highly similar epitope sequences (see
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Figure 1 The percentage of rare and common 5-mers in DQ- and DR-associated epitopes. The figures
show the fraction of 5-mers found for certain times in the human proteome. DQ-associated epitopes con-
tained (A) less rare 5-mers and (B) a higher number of common 5-mers than DR-associated sequences.
5-mer composition of 815 human epitopes (green) is also shown on the figures. Dashed lines represent
different cutoffs used for defining (A) rare 5-mers and (B) common 5-mers. P values represent the prob-
ability of having the same or higher difference between the number of rare and common 5-mers in DQ
and DR-associated epitopes by chance (see Methods). Note that in case of common alleles, both horizon-
tal and vertical axes were log-transformed for better visualization.
Full-size DOI: 10.7717/peerj.5118/fig-1
Methods). The filtering process resulted in 1476 DQ and 4077 DR-associated epitopes.
We decomposed each epitope to 5-mers and determined the number of times each 5-mer
can be found in the human proteome. Then, for both DQ and DR-associated epitopes,
we calculated the percentage of 5-mers that can be found for certain times in the human
proteome. The percentage of rare 5-mers indicates the similarity of epitope set to the
human proteome: the lower number of rare 5-mers can be found in epitope sequences, the
more similar these epitopes are to human proteins. As expected, DQ-associated epitopes
contained a significantly lower number of rare 5-mers, than DR-associated epitopes
(Fig. 1A). Moreover, common 5-mers occurring 30 or more times in the human proteome
could be found more frequently in DQ-associated epitopes (Fig. 1B).
HLA-DQ and HLA-DR molecules bind different pathogen species
As DQ-associated epitopes show higher similarity to human proteins, DQ and DR
might be responsible for the recognition of different pathogen species. To test this, we
downloaded HLA-II epitopes of pathogen species from IEDB. We discarded peptide
sequences of obligate intracellular pathogens as they are predominantly presented in an
MHC-I dependent manner (Hewitt, 2003). We also excluded highly similar sequences
from analysis (see Methods). We kept microbes having at least 25 documented epitopes
in IEDB and predicted the binding of each epitope by 73 common HLA-DRB1 alleles and
168 common HLA-DQA1-DQB1 allele pairs using NetMHCIIpan-3.1. This is reported
to be the most accurate prediction algorithm for MHC class II molecules (Andreatta et
al., 2017). For each microbe, we determined the ratio of epitopes bound by each allele.
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Figure 2 HLA-DQ and DRmolecules bind epitopes of different microbes. The heatmap shows epitope
binding by different DQA1-DQB1 allele pairs and DRB1 alleles color coded. In case of each species, col-
ors represent the portion of epitopes recognized by each allele or allele pair. Each row corresponds to a
DRB1 allele or DQ allele pair. Rows are clustered using hierarchical clustering (see Methods). DRB1 and
DQ molecules are clearly separated based on their species preference (marked with a horizontal line). Epi-
topes of species on the left are preferred by DR (marked with blue color in the table) and on the right are
preferred by DQ molecules (marked with green color in the table). Values were centered and scaled before
being clustered and visualized. The ratio between the mean proportion of epitopes bound by DQ allele
pairs and DR alleles (DQ/DR) is shown in the table for each species. Note that although computational
prediction indicated similar recognition ofM. tuberculosis (*) andM. leprae (*) by DQ and DR, analysis of
in vitro data showed significantly higher binding scores of these species for DQ (Table S2). Consequently,
they were classified into the DQ-associated group. Pcorr represents FDR-corrected P values of Wilcoxon
rank sum test. Pcorr values lower than 0.1 were considered to be significant and highlighted with red color.
Full-size DOI: 10.7717/peerj.5118/fig-2
Next, we used hierarchical clustering to identify similarities between the species-preference
of different alleles. DQ and DRB1 alleles clearly separated from each other making up
two different clusters (Fig. 2). Additionally, DQ and DR alleles bound markedly different
microbial species. We aimed to confirm these results with in vitro binding data. To this
end, binding probability scores were calculated for each pathogen-associated epitope (see
‘Methods’ for details). Briefly, we determined the prevalence of each amino acid at the 15
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amino acid positions for both DQ and DR-associated epitopes. We used epitope sets of
the 5-mer analysis for this purpose. Amino acid prevalence values were then applied to
calculate scores, which reflect the binding probability of a given epitope by DQ and DR
molecules. Reassuringly, majority of results held when using empirical binding data (Fig. 2,
Table S2).
The binding of auto-epitopes by HLA-DQ molecules protects from
autoimmune diseases
The preferred binding of human epitopes by DQ and previous evidence suggest, that these
molecules might play an important role in the induction of tolerance to self-epitopes.
Consequently, the binding of well-known epitopes of autoantigens (i.e., auto-epitopes)
by DQ molecules might protect from, while lack of binding might confer susceptibility to
autoimmune diseases. A straightforward prediction of these assumptions is that protective
HLA-DQ alleles bind more, while risk HLA-DQ alleles bind less auto-epitopes than neutral
alleles. To test these predictions, we collected 32 associations between 19 alleles of the
DQA1, DQB1 and DRB1 loci and six autoimmune diseases from the PheWAS catalog
(Karnes et al., 2017) (Table S3). For each disease, we collected disease-associated epitopes
from IEDB (Vita et al., 2015). Epitope-binding by DQ is determined by both alpha and
beta chains. Consequently, we calculated the characteristic level of auto-epitope binding by
a given protective or risk allele by considering all DQA1-DQB1 combinations, in which the
allele is included (see Methods). We found that the binding of disease-associated epitopes
by DQ alleles negatively correlated with the allele-associated risk for autoimmune diseases
(Fig. 3A). This relationship was independent of the autoimmune disease type and loci
of DQ (DQA1 or DQB1) (Table 1). We got the same results, if we used the amino acid
position dataset of PheWAS catalog instead of exact alleles (Fig. 3B, Table 1 and Table S3).
As expected, protective alleles bound a higher, while susceptibility alleles bound a lower
portion of disease-associated epitopes than neutral ones (Kruskal-Wallis P = 9∗ 10−5,
Fig. 4). No significant difference was found between autoantigen-binding by protective,
neutral and susceptibility alleles of HLA-DR (Kruskal-Wallis P = 0.18).
DISCUSSION
The equilibrium between immune defense mechanisms and tolerance is crucial for the
homeostasis of immunity. HLA molecules have a fundamental role in the regulation of
these processes as HLA-associated epitope presentation is one of the initial steps in the
afferent arm of immune response (Robinson & Delvig, 2002). The different HLA class II
loci are results of gene duplication events, and their evolution is relatively independent
from each other (Satta et al., 1994; Sommer, 2005; Valdes et al., 1999). Several previous
studies suggested a special—potentially suppressive—role of DQ molecules, but the
evidence is controversial and limited (Altmann, Sansom &Marsh, 1991; Hirayama et al.,
1987; Miyadera et al., 2015; Ottenhoff et al., 1990; Salgame, Convit & Bloom, 1991; Todd,
1990).
We carried out a large-scale analysis of epitope binding by DQ and DR molecules.
We found a higher chance for binding human epitopes by HLA-DQ than HLA-DR. We
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Figure 3 Binding of auto-epitopes by HLA-DQ is associated with protection from autoimmune
diseases. The binding of disease-specific auto-epitopes inversely correlated with the disease risk
associated with (A) HLA-DQ alleles and (B) amino acids of HLA-DQ (Spearman’s rho:−0.69 and−0.64,
P = 4 ∗ 10−4 and 2 ∗ 10−8, respectively). Horizontal axes indicate the portion of disease-associated
auto-epitopes bound by (A) the given allele or (B) amino acid (see Methods). Vertical axes show the risk
for autoimmune disease associated with (A) the given allele or (B) amino acid. Red dashed lines represent
linear regression lines. Note, that vertical axes are on a logarithmic scale.
Full-size DOI: 10.7717/peerj.5118/fig-3
Table 1 The relationship between auto-epitope binding by HLA-DQmolecules and protection from autoimmune diseases is independent
of disease types and DQ chains. To test, whether the relationship between binding auto-epitopes and risk for autoimmune diseases is caused by
disease- or DQ chain-specific differences in the epitope-binding of alleles, we constructed multivariate models: (1) log(OR)∼ Frallele+ Disease+
Chain, (2) log(OR)∼ Framino acid+ Disease+ Chain, where OR is the odds ratio for developing the given disease; Frallele is the level of disease-
associated auto- epitope binding by the DQ allele; Framino acid is the level of disease-associated auto-epitope binding by DQ alleles, which contain the
given amino acid and; Chain (i.e., DQA1 or DQB1) and Disease are categorical variables. Frallele and Framino acid showed negative effect on OR after
controlling for diseases and DQ chains. Significant relationship between predictor and response variables is marked with red color.
Allele associations Amino acid associations
Variable Slope Variance
explained
P Variable Slope Variance
explained
P
Frallele – 0.4 0.01 Framino acid – 0.39 0.008
Disease NA 0.17 NA Disease NA 0.08 NA
Chain + (DQB1) 0.02 0.47 Chain − (DQB1) 0.08 0.004
R2 0.38 (P = 0.046) 0.5 (P = 6∗10−8)
N 22 61
BP test P 0.2 0.11
Notes.
Variance expained: The proportion of variance in log(OR) explained by the given predictor variable; P : the probability of observing relationship between the predictor and re-
sponse variables by chance; R2: Total variance in log(OR) explained by the model (P corresponds to F-test P value); N : number of associations between autoimmune diseases
and alleles or amino acids; BP test P : the P value for Breusch-Pagan test of heteroscedasticity, P values larger than 0.05 suggest lack of heteroscedasticity.
utilized an established 5-mer based approach to compare pathogen-associated epitopes with
human proteins and found that DQ-bound epitopes are more similar to self-proteins than
DR-bound ones (Fig. 1). Trost et al. (2012)—using the same 5-mer based approach—found
that bacteria causing chronic infections are more similar to the human proteome (i.e., they
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Figure 4 Protective DQ alleles bindmore, while risk DQ alleles bind less autoimmune disease-
associated epitopes than neutral ones. Boxplot indicates median (horizontal line), the first and third
quartile (bottom and top of boxes) and minimum and maximum values (vertical lines). The bound
portion of auto-epitopes of the given disease that is associated with the given allele is shown for protective
and susceptibility groups. The portion of all auto-epitopes bound by each allele is shown for the neutral
allele group. * Pcorr < 0.005 (pairwise Wilcoxon test), ** Pcorr < 0.01 (pairwise Wilcoxon test)
Full-size DOI: 10.7717/peerj.5118/fig-4
contain a lower number of rare 5-mers) (Trost et al., 2012). This is in line with another study
suggesting that rare 5-mers cause a more intense immune response than common ones
(Patel et al., 2012). We characterized the binding of pathogen-associated epitopes by DQ
andDR and found that DQ andDRmolecules present peptides of rather differentmicrobial
species (Fig. 2). While DR molecules bind pathogens associated with acute infections, DQ
alleles also recognize epitopes of pathogens causing chronic infections (M. tuberculosis,
M. leprae) (Russell, 2011; Yamamura et al., 1991) or evading immune system and having a
high relapse rate after therapy (B. pseudomallei) (Currie et al., 2000).
Finally, our results suggest that DQ molecules have an essential role in the development
of central tolerance by presenting self-epitopes. This is in line with previous findings:
(i) non-stable binding of peptides by HLA-DQ resulted in thymic escape of autoreactive
T-cells (Dendrou et al., 2018) and (ii) autoimmune dermatitis developed in transgenic
mice expressing an HLA-DQ ortholog I-Ab complex, which can bind only one epitope
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(Logunova et al., 2005). In these mice, autoreactive cells could be maintained due to the
lack of negative selection of T cells, which recognize self-peptides by MHC-II dependent
presentation. We examined six different autoimmune diseases and found that the hazard
ratio associated with a given HLA-DQ allele inversely correlated with the proportion
of bound disease-associated epitopes (Fig. 3, Table 1). Additionally, neutral DQ alleles
bound less epitopes than protective and more epitopes than risk alleles (Fig. 4). This result
indicates, that a certain level of auto-epitope binding by DQ molecules is needed for a
healthy immune-homeostasis. Alleles binding less auto-epitopes might allow thymic escape
of self-reactive T cells and make the individual susceptible to autoimmune diseases.
CONCLUSIONS
Previous pieces of evidence suggested a suppressive role of HLA-DQmolecules in immune
homeostasis, but this hypothesis remained controversial. We tested relevant predictions
of the hypothesis. We found that DQ molecules bind more human epitopes than DR.
Accordingly, pathogen-assocated epitopes bound by DQ are more similar to human
proteins than the ones bound by DR. DQ molecules bind mainly epitopes of pathogens
associated with chronic or relapsing infectious diseases. This indicates the importance
of DQ-mediated tolerance induction for the immune evasion of pathogens. Our results
also suggest that DQ molecules might have a more important role in inducing tolerance
than in activating proliferative and destructive responses during the development of
autoimmune diseases. All of our findings suggest an essential role of HLA-DQ molecules
in tolerance formation and might help to better understand the role of HLA molecules in
the development of infectious and autoimmune diseases.
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